Half-year report · HY
286A.TEDINET S100YWR5
Period2026-01-01 → 2026-06-30
Filed2026-08-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥13.7bn | 2026-01-01 → 2026-06-30 | Cons. | Net sales |
| Revenue | ¥24.7bn | 2025-01-01 → 2025-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥10.5bn | 2025-01-01 → 2025-06-30 | Cons. | Net sales |
| Operating income | ¥395m | 2026-01-01 → 2026-06-30 | Cons. | Operating income |
| Operating income | ¥1.1bn | 2025-01-01 → 2025-06-30 | Cons. | Operating income |
| Ordinary income | ¥361m | 2026-01-01 → 2026-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥2.1bn | 2025-01-01 → 2025-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥981m | 2025-01-01 → 2025-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥256m | 2026-01-01 → 2026-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥1.2bn | 2025-01-01 → 2025-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥489m | 2026-01-01 → 2026-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.8bn | 2025-01-01 → 2025-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥824m | 2025-01-01 → 2025-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥560m | 2026-01-01 → 2026-06-30 | Cons. | Profit loss |
| Net income | ¥887m | 2025-01-01 → 2025-06-30 | Cons. | Profit loss |
| Total assets | ¥67.5bn | at 2026-06-30 | Cons. | Assets |
| Total assets | ¥65.1bn | at 2025-12-31 | Cons. | Assets |
| Total assets | ¥61.2bn | at 2025-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥45.2bn | at 2026-06-30 | Cons. | Liabilities |
| Total liabilities | ¥43.3bn | at 2025-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥22.3bn | at 2026-06-30 | Cons. | Net assets |
| Net assets / equity | ¥21.8bn | at 2025-12-31 | Cons. | Net assets |
| Net assets / equity | ¥19.7bn | at 2025-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥11.0bn | at 2026-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥9.1bn | at 2025-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥10.9bn | at 2026-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥9.1bn | at 2025-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.2bn | at 2025-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥11.1bn | at 2024-12-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥551m | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥1.9bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥1.6bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | ¥92m | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.3bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥2.4bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥1.2bn | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥1.8bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥856m | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥13.67 | 2026-01-01 → 2026-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥78.07 | 2025-01-01 → 2025-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥23.2 | 2025-01-01 → 2025-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥13.57 | 2026-01-01 → 2026-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥76.75 | 2025-01-01 → 2025-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥22.75 | 2025-01-01 → 2025-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 31.2% | at 2026-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 31.5% | at 2025-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 30.3% | at 2025-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 50
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2026-01-01 → 2026-06-30 | ¥376m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2026-01-01 → 2026-06-30 | ¥376m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2026-01-01 → 2026-06-30 | ¥118m |
| Reconciling Itemsreconciling | revenue | 2026-01-01 → 2026-06-30 | −¥16m |
| Reconciling Itemsreconciling | revenue intersegment | 2026-01-01 → 2026-06-30 | −¥16m |
| Reconciling Itemsreconciling | segment profit | 2026-01-01 → 2026-06-30 | −¥731m |
| Comprehensive Medical Management Support Businessreportable segment | revenue | 2026-01-01 → 2026-06-30 | ¥5.1bn |
| Comprehensive Medical Management Support Businessreportable segment | revenue external | 2026-01-01 → 2026-06-30 | ¥5.0bn |
| Comprehensive Medical Management Support Businessreportable segment | revenue intersegment | 2026-01-01 → 2026-06-30 | ¥15m |
| Comprehensive Medical Management Support Businessreportable segment | segment profit | 2026-01-01 → 2026-06-30 | ¥457m |
| Elderly Care Related Businessreportable segment | revenue | 2026-01-01 → 2026-06-30 | ¥4.4bn |
| Elderly Care Related Businessreportable segment | revenue external | 2026-01-01 → 2026-06-30 | ¥4.4bn |
| Elderly Care Related Businessreportable segment | revenue intersegment | 2026-01-01 → 2026-06-30 | ¥740,000 |
| Elderly Care Related Businessreportable segment | segment profit | 2026-01-01 → 2026-06-30 | ¥312m |
| Specially Controlled Medical Device Businessreportable segment | revenue | 2026-01-01 → 2026-06-30 | ¥3.8bn |
| Specially Controlled Medical Device Businessreportable segment | revenue external | 2026-01-01 → 2026-06-30 | ¥3.8bn |
| Specially Controlled Medical Device Businessreportable segment | segment profit | 2026-01-01 → 2026-06-30 | ¥240m |
| —segment total | revenue | 2026-01-01 → 2026-06-30 | ¥13.3bn |
| —segment total | revenue external | 2026-01-01 → 2026-06-30 | ¥13.3bn |
| —segment total | revenue intersegment | 2026-01-01 → 2026-06-30 | ¥16m |
| —segment total | segment profit | 2026-01-01 → 2026-06-30 | ¥1.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2026-01-01 → 2026-06-30 | ¥13.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2026-01-01 → 2026-06-30 | ¥13.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2026-01-01 → 2026-06-30 | ¥16m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2026-01-01 → 2026-06-30 | ¥1.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2025-01-01 → 2025-06-30 | ¥219m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2025-01-01 → 2025-06-30 | ¥219m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2025-01-01 → 2025-06-30 | ¥41m |
| Reconciling Itemsreconciling | revenue | 2025-01-01 → 2025-06-30 | −¥640,000 |
| Reconciling Itemsreconciling | revenue intersegment | 2025-01-01 → 2025-06-30 | −¥640,000 |
| Reconciling Itemsreconciling | segment profit | 2025-01-01 → 2025-06-30 | −¥670m |
| Comprehensive Medical Management Support Businessreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥3.1bn |
| Comprehensive Medical Management Support Businessreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥3.1bn |
| Comprehensive Medical Management Support Businessreportable segment | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥395,000 |
| Comprehensive Medical Management Support Businessreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥1.3bn |
| Elderly Care Related Businessreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥3.7bn |
| Elderly Care Related Businessreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥3.7bn |
| Elderly Care Related Businessreportable segment | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥245,000 |
| Elderly Care Related Businessreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥187m |
| Specially Controlled Medical Device Businessreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥3.6bn |
| Specially Controlled Medical Device Businessreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥3.6bn |
| Specially Controlled Medical Device Businessreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥276m |
| —segment total | revenue | 2025-01-01 → 2025-06-30 | ¥10.3bn |
| —segment total | revenue external | 2025-01-01 → 2025-06-30 | ¥10.3bn |
| —segment total | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥640,000 |
| —segment total | segment profit | 2025-01-01 → 2025-06-30 | ¥1.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-01-01 → 2025-06-30 | ¥10.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-01-01 → 2025-06-30 | ¥10.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥640,000 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-01-01 → 2025-06-30 | ¥1.8bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 552
| Item | Context | Value | Unit |
|---|---|---|---|
| Name major shareholders | InterimInstant_No2MajorShareholdersMember | Original text (Japanese)古川 淳 | |
| Address major shareholders | InterimInstant_No2MajorShareholdersMember | Original text (Japanese)東京都千代田区 | |
| Name major shareholders | InterimInstant_No3MajorShareholdersMember | Original text (Japanese)株式会社日本カストディ銀行（信託口） | |
| Address major shareholders | InterimInstant_No3MajorShareholdersMember | Original text (Japanese)東京都中央区晴海1-8-12 | |
| Name major shareholders | InterimInstant_No4MajorShareholdersMember | Original text (Japanese)株式会社クラリバ | |
| Address major shareholders | InterimInstant_No4MajorShareholdersMember | Original text (Japanese)東京都千代田区二番町5-25 | |
| Name major shareholders | InterimInstant_No5MajorShareholdersMember | Text · Plus | |
| Address major shareholders | InterimInstant_No5MajorShareholdersMember | Text · Plus | |
| Name major shareholders | InterimInstant_No6MajorShareholdersMember | Original text (Japanese)住友生命保険相互会社（常任代理人 株式会社日本カストディ銀行） | |
| Address major shareholders | InterimInstant_No6MajorShareholdersMember | Original text (Japanese)東京都中央区八重洲2-2-1 （東京都中央区晴海1-8-12） | |
| Name major shareholders | InterimInstant_No7MajorShareholdersMember | Original text (Japanese)SBI Ventures Two 株式会社 | |
| Address major shareholders | InterimInstant_No7MajorShareholdersMember | Original text (Japanese)東京都港区六本木1-6-1 | |
| Name major shareholders | InterimInstant_No8MajorShareholdersMember | Original text (Japanese)株式会社シグマクシス・ホールディングス | |
| Address major shareholders | InterimInstant_No8MajorShareholdersMember | Original text (Japanese)東京都港区虎ノ門4-1-28 | |
| Name major shareholders | InterimInstant_No9MajorShareholdersMember | Original text (Japanese)日本証券金融株式会社 | |
| Address major shareholders | InterimInstant_No9MajorShareholdersMember | Original text (Japanese)東京都中央区日本橋茅場町1-2-10 | |
| Name major shareholders | InterimInstant_No10MajorShareholdersMember | Original text (Japanese)三井住友信託銀行株式会社 （常任代理人 株式会社日本カストディ銀行） | |
| Address major shareholders | InterimInstant_No10MajorShareholdersMember | Original text (Japanese)東京都千代田区丸の内1-4-1 （東京都中央区晴海1-8-12） | |
| Issued shares voting rights (text) | FilingDateInstant | Text · Plus | |
| Description issued shares voting rights | InterimInstant_SharesWithNoVotingRightsMember | － | |
| Description issued shares voting rights | InterimInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | InterimInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Description issued shares voting rights | InterimInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | InterimInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | － | |
| Description issued shares voting rights | InterimInstant_OrdinarySharesSharesLessThanOneUnitMember | － | |
| Treasury shares etc (text) | FilingDateInstant | Text · Plus | |
| Name of shareholder treasury shares etc | InterimInstant_Row1Member | Original text (Japanese)株式会社ユカリア | |
| Address of shareholder treasury shares etc | InterimInstant_Row1Member | Original text (Japanese)東京都千代田区霞が関3-2-5 | |
| Information about officers (text) | FilingDateInstant | Text · Plus | |
| Regulations in accordance with which consolidated financial statements have been prepared financial information | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated financial statements financial information | InterimDuration | Text · Plus | |
| Note on independent audit financial information | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated balance sheet (text) | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated statement of income (text) | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated statement of comprehensive income (text) | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated statement of cash flows (text) | InterimDuration | Text · Plus | |
| Notes changes in scope of consolidation or equity method (text) | InterimDuration | Text · Plus | |
| Notes changes in presentation semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Notes regarding guarantee obligations (text) | InterimInstant | Text · Plus | |
| Major components of selling general and administrative expenses (text) | InterimDuration | Text · Plus | |
| Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text) | InterimDuration | Text · Plus | |
| Notes segment information etc type1 semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | Prior1InterimDuration | Text · Plus | |
| Information about impairment loss of non current assets or goodwill etc for each reportable segment (text) | Prior1InterimDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | InterimDuration | Text · Plus | |
| Information about impairment loss of non current assets or goodwill etc for each reportable segment (text) | InterimDuration | Text · Plus | |
| Disclosure of changes etc in reportable segments (text) | InterimDuration | Text · Plus | |
| Notes revenue recognition semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Notes per share information semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Notes significant events after reporting period semi annual consolidated financial statements (text) | InterimDuration | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |